Projects

Dr. Dhinagaran - M44 eLearning Consultation for Ministry of Health, Govt. of Thailand

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2020 - 2029

Project Lead

Dr. Dhinagaran

Authors

Dr. Dhinagaran

Project Status

ongoing

Project Type

ICMR-extramural